Floatz logo

Bxcl501

Postoperative Complications

Kaohsiung Medical University Chung-Ho Memorial HospitalPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Postoperative Complications cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
China Meitan General Hospital
Phase 4BB
FLUOROURACILUM
China Meitan General Hospital
Phase 4BB
Dc-Cik
China Meitan General Hospital
Phase 4BB
Eloxatin
China Meitan General Hospital
Phase 4BB
DEXAMETHASONE
Rigshospitalet, Denmark
Phase 4BB

View all 18 →

Same molecule, other indications

Bxcl501 is also rated in:

Pain, ChronicDormant
A
Indicative ·
80 / 100
View asset →
Agitation,PsychomotorDormant
A
Indicative ·
80 / 100
View asset →
schizophreniform disorderDormant
A
Indicative ·
80 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →